Drug and Alcohol Rehabilitation: [Fluorimetric Analysis of Camptothecin in Chinese Herbal Medicine Common Camptotheca Fruit].

[Fluorimetric analysis of camptothecin in Chinese herbal medicine common Camptotheca fruit].

Filed under: Drug and Alcohol Rehabilitation

Yao Xue Xue Bao. 2012 Oct; 47(10): 1370-4
Wang LP, Wei YJ

Three-dimensional (3D) fluorescence spectra and thin layer fluorescence chromatogram of common Camptotheca fruit (CCF) crude drug, camptothecin (CPT) and 10-hydroxycamptothecin (HCPT) have been studied, and a novel fluorimetric method for determination of CPT in CCF crude drug has been established. In 3D fluorescence spectra, CPT presented 3 fluorescence peaks with excitation wavelengths lambdaex of 215, 255 and 365 nm, separately, and all peaks with emission wavelength lambdaem of 430 nm. HCPT presented 4 fluorescence peaks with lambdaex of 220, 265, 325 and 375 nm, separately, and all peaks with lambdaem of 555 nm. The fluorescence of CPT is much stronger than that of HCPT. Comparison of 3D fluorescence spectra and analysis of thin layer fluorescence chromatogram revealed that the main fluorescent component of CCF is CPT. HCPT and other components basically do not interfere with the fluorescence of CPT. Under the condition of pH 3.0-6.7, CCF aqueous solution can produce strong and steady fluorescence. Using methanol as solvent, the extracting solution of CCF was prepared, and diluted properly with water, then measured fluorescence intensity at lambdaex/lambdaem = 365/430 nm to determine the content of CPT. A linear calibration curve covered the concentration range 0.002 35-0.235 microg x mL(-1). The regression equation was IF = 9 + 30,844 c, with correlation coefficient r = 0.999 (n=9). The method has been applied to the analysis of CPT in a CCF sample, with a result of 0.127% and a spiked recovery rate of 102%. The reliability of the method has been verified by a thin layer chromatography-fluorescence scanning method. Experimental results demonstrated that this method can be used for quality evaluation of CCF crude drug.
HubMed – drug


[Pharmacokinetics of S-1 capsule in patients with advanced gastric cancer].

Filed under: Drug and Alcohol Rehabilitation

Yao Xue Xue Bao. 2012 Oct; 47(10): 1363-9
Liu HY, Ding L, Yu Y, Chu Y, Zhu H

The study is to investigate the pharmacokinetics of S-1 capsule (tegafur, gimeracil and potassium oxonate capsule) in patients with advanced gastric cancer after single and multiple oral administration. Twelve patients with advanced gastric cancer were recruited to the study. The dose of S-1 for each patient was determined according to his/her body surface area (BSA). The dose for single administration was 60 mg every subject. The dose for multiple administration for one subject was as follows: 100 mg x d(-1) or 120 mg x d(-1), 28-days consecutive oral administration. The pharmacokinetic parameters of tegafur, 5-fluorouracil, gimeracil, potassium oxonate and uracil after single oral administration were as follows: (2,207 +/- 545), (220.0 +/- 68.2), (374.9 +/- 103.0), (110.5 +/- 100.8) and (831.1 +/- 199.9) ng x mL(-1) for Cmax; (11.8 +/- 3.8), (4.4 +/- 3.3), (7.8 +/- 5.1), (3.1 +/- 0.9) and (8.8 +/- 4.1) h for t1/2, respectively. After six days oral administration, the average steady state plasma concentrations (Cav) of tegafur, 5-fluorouracil, gimeracil, potassium oxonate and uracil were (2,425 +/- 1,172), (73.88 +/- 18.88), (162.6 +/- 70.8), (36.89 +/- 29.35) and (435.3 +/- 141.0) ng x mL(-1), respectively, and the degree of fluctuation (DF) were (1.0 +/- 0.2), (2.5 +/- 0.4), (3.1 +/- 0.8), (2.4 +/- 0.8) and (1.5 +/- 0.3), respectively. The cumulative urine excretion percentage of tegafur, 5-fluorouracil, gimeracil and potassium oxonate in urine within 48 h were (4.2 +/- 2.8) %, (4.7 +/- 1.6) %, (18.5 +/- 6.0) % and (1.7 +/- 1.2) %, repectively, after single oral administration of S-1. The results exhibited that tegafur had some drug accumulation observed, and gimeracil, potassium oxonate, 5-fluorouracil and uracil had no drug accumulation observed.
HubMed – drug


[Ribosome display screening of a novel human anti-IgE scFv fragment].

Filed under: Drug and Alcohol Rehabilitation

Yao Xue Xue Bao. 2012 Oct; 47(10): 1329-35
Zhang YX, Wang BC, Yu X, Dai YJ, He YZ, Cong C, Xia Y, Wang MR

Total mRNA was extracted from lymphocytes separated from the peripheral blood of allergic patients, and then variable region of heavy chain (VH) and variable region of light chain (VL) cDNA library were constructed by RT-PCR. Human scFv templates for rabbit reticulocyte lysate ribosome display were assembled by primers and linker peptide (Gly4Ser)3. mRNA bound in antibody-ribosome-mRNA complexes was recovered using in-situ single primer RT-PCR, and three rounds of anti-IgE scFv DNA were enriched. The target DNA fragments were double enzyme digested and ligated into plasmid pET22b (+), followed by transformation in E. coli Rosseta (DE3). Positive clones were screened using clone PCR, Dot blotting and antigen ELISA. The correct lengths of VH (400 bp) and VL (710 bp) PCR products were obtained. The expected 1,000 bp ribosome display templates were also observed in agarose gel electrophoresis. After three rounds of ribosome display target sequences were effectively enriched, leading to a library of 10(13) members. Antibodies with the highest ELISA value for IgE were generated in the strain pET-IgE-6. A human anti-IgE scFv library was successfully constructed as described herein. Ribosome display using single primer in-situ RT-PCR as the recovery procedure effectively enriched target sequences. Anti-IgE scFv with high affinity and specificity were identified. The prepared human anti-IgE scFv fragment might be self-developed to a lead drug for treating asthma. Our study provides an alternative method for rapid discovery of human antibodies of therapeutic importance.
HubMed – drug



News on 6 Tulsa Narconon Arrowhead Stacy Dawn Murphy – Oklahoma’s Own News on 6 Tulsa Parents File Lawsuit Against Narconon After Owasso Woman Dies In Treatment Posted: Oct 05, 2012 2:17 PM CDT Updated: Oct 05, 2012 4:41 PM CDT Brandi Ball, NewsOn6.com “McALESTER, Oklahoma – The parents of an Owasso woman found dead at a drug and alcohol rehabilitation center have filed a lawsuit against the facility in Pittsburg County District Court. Plaintiffs are Oklahoma residents Robert Murphy and Tonya White, parents of 20-year-old Stacy Dawn Murphy, who was found dead in the facility’s withdrawal unit on July 19. The lawsuit filed on Friday alleges wrongful death, negligence, and violation of the Oklahoma Consumer Protection Act. It lists the defendants as nonprofit Narconon Arrowhead, Narconon International, the Association for Better Living and Education International and Gerald D. Wootan, medical director of Narconon Arrowhead. The defendants “all rely exclusively upon the written ‘technology’ of L. Ron Hubbard, the founder of the Church of Scientology… despite the fact that Hubbard has no known training or education in the field of drug and alcohol rehabilitation,” the lawsuit alleges.” Read More: www.newson6.com


More Drug And Alcohol Rehabilitation Information…